Second primary malignancies after stereotactic body radiotherapy vs surgery for early-stage lung cancer: a U.S. population-based study, 2010-2015
Background: Stereotactic body radiotherapy (SABR) plays an essential role in the curative treatment of early-stage lung cancer. Second primary malignancy (SPM) has become a significant concern in lung cancer management because of the increasing number of cancer survivors. However, whether SABR incre...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2026-01-01
|
| Colección: | Cancer Treatment and Research Communications |
| Materias: | |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S246829422600122X |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|